Cargando…

The Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Improving Morbidity and Mortality of Heart Failure: A Systematic Review

Cardiovascular disease (CVD) is the leading cause of mortality in patients with type 2 diabetes mellitus (DM) worldwide. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) were initially developed for treating patients with type 2 DM. The four major drugs developed are canagliflozin, dapagliflozin,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thiagaraj, Suvedha, Shukla, Twisha S, Gutlapalli, Sai Dheeraj, Farhat, Hadi, Irfan, Huma, Muthiah, Kanmani, Pallipamu, Namratha, Taheri, Sogand, Khan, Safeera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016728/ https://www.ncbi.nlm.nih.gov/pubmed/36938250 http://dx.doi.org/10.7759/cureus.34942

Ejemplares similares

A Systematic Review of How To Reduce Morbidity in HIV Patients With Cardiovascular Diseases
por: Pallipamu, Namratha, et al.
Publicado: (2023)

The Anti-Depressant Effects of Statins in Patients With Major Depression Post-Myocardial Infarction: An Updated Review 2022
por: Gutlapalli, Sai Dheeraj, et al.
Publicado: (2022)

Increased Risk of Cardiovascular Diseases in Rheumatoid Arthritis: A Systematic Review
por: Farhat, Hadi, et al.
Publicado: (2022)

The Usefulness of Combining Noninvasive Methods for Early Identification and Potential Prevention of Cystic Fibrosis-Associated Liver Disease
por: Shukla, Twisha S, et al.
Publicado: (2022)

A Review on Major Pathways Leading to Peritoneal Fibrosis in Patients Receiving Continuous Peritoneal Dialysis
por: Taheri, Sogand, et al.
Publicado: (2022)

Role of Glucagon-Like Peptide-1 Receptor Agonists on the Weight Loss of Individuals With Type 2 Diabetes: A Systematic Review
por: Irfan, Huma, et al.
Publicado: (2023)

Cardiovascular Benefit of Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Type 2 Diabetes: A Systematic Review
por: Georgiou, Petros, et al.
Publicado: (2021)

Comparing Triple Combination Drug Therapy and Traditional Monotherapy for Better Survival in Patients With High-Risk Hypertension: A Systematic Review
por: Zaman, Mustafa Abrar, et al.
Publicado: (2023)

Statins and Antidepressants: A Comprehensive Review and Clinical Outlook of the Risks and Benefits of Co-prescription (2022)
por: Gutlapalli, Sai Dheeraj, et al.
Publicado: (2022)

Anxiety and Depression as Risk Factors for Vasovagal Syncope and Potential Treatment Targets: A Systematic Review
por: Abuzainah, Baraa, et al.
Publicado: (2022)

Health Benefits of Esports: A Systematic Review Comparing the Cardiovascular and Mental Health Impacts of Esports
por: Seffah, Kofi D, et al.
Publicado: (2023)

Potential Benefits of Sodium-Glucose Transporter-2 Inhibitors in the Symptomatic and Functional Status of Patients With Heart Failure: A Systematic Review and Meta-Analysis
por: Bhalla, Sushen, et al.
Publicado: (2022)

Identifying the Incidence, Predictors, Outcomes, and Prevention of Stent Thrombosis (ST) in Post-percutaneous Coronary Revascularization Patients With Drug-Eluting Stents (DES): A Systematic Review
por: Sohail, Mehvish, et al.
Publicado: (2023)

Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Heart Failure: An Umbrella Review
por: Roy, Raj, et al.
Publicado: (2023)

Exploring the Potential of Energy-Based Therapeutics (Photobiomodulation/Low-Level Laser Light Therapy) in Cardiovascular Disorders: A Review and Perspective
por: Ganipineni, Vijay Durga Pradeep, et al.
Publicado: (2023)

The Effects of Resveratrol on Telomeres and Post Myocardial Infarction Remodeling
por: Gutlapalli, Sai Dheeraj, et al.
Publicado: (2020)

Effects of Sodium-Glucose Cotransporter Inhibitor Use in Type 2 Diabetes Mellitus Patients With Heart Failure
por: Choday, Silpa, et al.
Publicado: (2023)

A Paradigm Shift in the Management of Atherosclerosis: Protective Role of Sirtuins in Atherosclerosis
por: Toulassi, Ijeoma A, et al.
Publicado: (2021)

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) in Cardiovascular Disease: A Comprehensive Clinical Review on Dilated Cardiomyopathy
por: Ganipineni, Vijaya Durga Pradeep, et al.
Publicado: (2023)

Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors to Decrease the Risk of Cardiovascular Diseases: A Systematic Review
por: Moparthi, Kiran Prasad, et al.
Publicado: (2023)

Unmasking a Silent Killer and Understanding Sudden Cardiac Death in Brugada Syndrome: A Traditional Review
por: Moturu, Aadya, et al.
Publicado: (2023)

Sodium-glucose cotransporter 2 inhibitors in obese patients with heart failure
por: Kato, Shingo, et al.
Publicado: (2023)

Re-defining the Gut Heart Axis: A Systematic Review of the Literature on the Role of Gut Microbial Dysbiosis in Patients With Heart Failure
por: Desai, Darshi, et al.
Publicado: (2023)

The Significance of Sleep Disorders in Post-myocardial Infarction Depression
por: Gutlapalli, Sai Dheeraj, et al.
Publicado: (2022)

Sodium-Glucose Cotransporter 2 Inhibitors: A Scoping Review of the Positive Implications on Cardiovascular and Renal Health and Dynamics for Clinical Practice
por: Erdem, Saliha, et al.
Publicado: (2023)

Obesity and Coronary Artery Disease: An Updated Systematic Review 2022
por: Manoharan, Mohana Priya, et al.
Publicado: (2022)

Benefits of Taking Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: A Systematic Review
por: Sarker, Aditi, et al.
Publicado: (2022)

A Systematic Review Exploring the Cardiovascular and Renal Effects of Empagliflozin in Patients With Heart Failure With Reduced Ejection Fraction
por: Athiyaman, Sreekartthik, et al.
Publicado: (2022)

Sacubitril/Valsartan in Heart Failure Hospitalization: Two Pills a Day to Keep Hospitalizations Away?
por: Sakhamuri, Navya, et al.
Publicado: (2023)

Effectiveness of Catheter Ablation in Left Ventricular Ejection Fraction, Stroke, Quality of Life, All-Cause Mortality, Sinus Rhythm Maintenance, and Hospitalization Rates as Compared to Medical Therapy
por: Oble, Mrinal J P, et al.
Publicado: (2023)

Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors: Delving Into the Potential Benefits of Cardiorenal Protection Beyond the Treatment of Type-2 Diabetes Mellitus
por: Srinivas, Natasha, et al.
Publicado: (2021)

The Effects of Sodium-Glucose Cotransporter-2 Inhibitors (SLGT-2i) on Cardiovascular and Renal Outcomes in Non-diabetic Patients: A Systematic Review
por: Giri Ravindran, Suganya, et al.
Publicado: (2022)

The Risk of Fatal Arrhythmias Associated With Sertraline in Patients With Post-myocardial Infarction Depression
por: Gutlapalli, Sai Dheeraj, et al.
Publicado: (2022)

The Risk of Fatal Arrhythmias in Post-Myocardial Infarction Depression in Association With Venlafaxine
por: Gutlapalli, Sai Dheeraj, et al.
Publicado: (2022)

Sudden Cardiac Arrest in Athletes: A Primary Level of Prevention
por: Prakash, Keerthana, et al.
Publicado: (2022)

Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors and Genital Infections in Patients With Diabetic Mellitus and Concomitant Coronary Artery Disease: A Single-Center Experience
por: Shah, Bhupesh R, et al.
Publicado: (2022)

Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Patients With Diabetes and Chronic Kidney Disease (CKD): A Meta-analysis of Randomized Control Trials
por: Jamil, Sidra, et al.
Publicado: (2022)

Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Therapy for the Primary and Secondary Prevention of Heart Failure in Patients With and Without Type 2 Diabetes Mellitus: A Systematic Review
por: Wahinya, Maureen, et al.
Publicado: (2023)

A Study of Vitamin D and Its Correlation With Severity and Complication of Congestive Heart Failure: A Systematic Review
por: Hazique, Mohammad, et al.
Publicado: (2022)

Acquired Von Willebrand Deficiency in Adults With Aortic Stenosis: A Systematic Review
por: Ramesh, Prasana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8bn0b9n1f6hnd7mmtltdfqcdnp